Experiences of People Who Discontinue Long‐Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, Australia
Dados Bibliográficos
Buprenorphine · Continuation · Opioid use disorder · Prison · Psychosocial · HIV, Drug Use, Sexual Risk · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes
Meta‐analysis of drug‐related deaths soon after release from prison
Iterative categorization (IC)
Global patterns of opioid use and dependence
Long-Acting Injectable Buprenorphine for Opioid Use Disorder
Patient satisfaction with long-acting injectable buprenorphine
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open‐label, non‐randomised trial of long‐acting injectable buprenorphine treatment in Australian custodial settings
Community buprenorphine continuation post-release following extended release vs. sublingual buprenorphine during incarceration
Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada
The impact of substitution treatment in prisons—A literature review
Matters-of-concern’ associated with discontinuation of long-acting injectable buprenorphine
Health and correctional staff acceptability of depot buprenorphine in NSW prisons
Trust and service engagement among people who inject drugs after release from prison
Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022
I just thought that was the best thing for me to do at this point’
| Velocidade de citação | historical |
|---|---|
| Altamente citado | Não |